These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24699298)

  • 21. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy.
    Flidel-Rimon O; Friedman S; Gradstein S; Bardenstein R; Shinwell ES
    Acta Paediatr; 2003 Oct; 92(10):1205-7. PubMed ID: 14632339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns.
    Aurangzeb B; Hameed A
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):629-32. PubMed ID: 14700488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
    Düzova A; Kutluk T; Kanra G; Büyükpamukçu M; Akyüz C; Seçmeer G; Ceyhan M
    Turk J Pediatr; 2001; 43(2):105-9. PubMed ID: 11432485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal sepsis in a tertiary care center in central India: microbiological profile, antimicrobial sensitivity pattern and outcome.
    Mehar V; Yadav D; Somani P; Bhatambare G; Mulye S; Singh K
    J Neonatal Perinatal Med; 2013; 6(2):165-72. PubMed ID: 24246519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.
    Velaphi S; Wadula J; Nakwa F
    Ann Trop Paediatr; 2009 Jun; 29(2):101-10. PubMed ID: 19460263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time trends in the epidemiology of microbial infections at a tertiary care center in west India over last 5 years.
    Patel AK; Patel KK; Patel KR; Shah S; Dileep P
    J Assoc Physicians India; 2010 Dec; 58 Suppl():37-40. PubMed ID: 21563612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-drug-resistant, non-fermenting, gram-negative bacilli in neonatal sepsis in Kolkata, India: a 4-year study.
    Viswanathan R; Singh AK; Basu S; Chatterjee S; Roy S; Isaacs D
    Paediatr Int Child Health; 2014 Feb; 34(1):56-9. PubMed ID: 24090966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis.
    Shenoi A; Nagesh NK; Maiya PP; Bhat SR; Subba Rao SD
    Indian Pediatr; 1999 Nov; 36(11):1113-8. PubMed ID: 10745332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of intramuscular antibiotics for secondary prevention of early onset, asymptomatic 'suspected' neonatal sepsis.
    Lambert B; Nafday SM; Campbell DE; Woodrooffe K; Kim M
    J Perinatol; 2012 Jun; 32(6):454-9. PubMed ID: 21869767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset Enterobacter cloacae sepsis in very-low-birth-weight neonates: experience in a medical center.
    Chen HN; Lee ML; Yu WK; Lin YW; Tsao LY
    Pediatr Neonatol; 2009 Feb; 50(1):3-7. PubMed ID: 19326831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Rizal AM; Nordiah AJ; Jamal R
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapartum antibiotics and risk factors for early onset sepsis.
    Dutta S; Reddy R; Sheikh S; Kalra J; Ray P; Narang A
    Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F99-103. PubMed ID: 19996327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
    Goel A; Nangia S; Saili A; Garg A; Sharma S; Randhawa VS
    Eur J Pediatr; 2015 Feb; 174(2):237-43. PubMed ID: 25084971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
    Bow EJ; Rotstein C; Noskin GA; Laverdiere M; Schwarer AP; Segal BH; Seymour JF; Szer J; Sanche S
    Clin Infect Dis; 2006 Aug; 43(4):447-59. PubMed ID: 16838234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.